United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 2 minute read Pharma Industry News XtalPi raises $319m for AI based drug research and development XtalPi, a pharma company that leverages artificial intelligence (AI) for drug discovery and development, has raised $318.8 million… bypharmanewsdailySeptember 28, 2020